All tumors | ER-negative | ER-positive | Her2 low | Her2 high | ER-negative/HER2 high | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Spearman rank correlation | ρ | p-value | ρ | p | ρ | p | ρ | p | ρ | p | ρ | p |
pAkt Ser473 | 0.23 | <0.001 | 0.24 | 0.011 | 0.22 | 0.006 | 0.18 | 0.024 | 0.33 | 0.001 | 0.50 | 0.003 |
pAkt Thr308 | 0.26 | <0.001 | 0.25 | 0.009 | 0.26 | 0.001 | 0.23 | 0.003 | 0.36 | <0.001 | 0.51 | 0.003 |
pCasp9 Ser196 | 0.30 | <0.001 | 0.31 | 0.001 | 0.30 | <0.001 | 0.25 | 0.001 | 0.40 | <0.001 | 0.67 | <0.001 |
pBAD Ser136 | 0.20 | 0.001 | 0.26 | 0.008 | 0.15 | 0.063 | 0.13 | 0.084 | 0.31 | 0.002 | 0.57 | <0.001 |
CD31 | 0.05 | 0.402 | 0.10 | 0.302 | 0.01 | 0.85 | -0.02 | 0.799 | 0.19 | 0.084 | 0.41 | 0.021 |